ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Registrieren

Bereits Mitglied? Einloggen

Pepperstone

Jetzt Handeln

Pepperstone
Marktdaten
News
Werkzeuge
Märkte
Entdecken

Hot Features

Follow Feed

Vernetzen Sie sich mit Händlern und Investoren in unserer Follow-Feed-Community.

Optionen-Flow

Erkunden Sie umfassende Optionsdaten und nutzen Sie erweiterte Filter mit Options Flow.

Watchlist

Organisieren und überwachen Sie Ihre Aktien- und Vermögensbeobachtungsliste mit dem Monitor.
Anmelden Premium IconPremium Help Menu
DAX
22.513,42
-0,43%
S&P 500
6.114,63
-0,01%
Dow Jones
44.546,08
-0,37%
Euro vs US Dollar
1,04955
0,00%
Bitcoin
96.970,10
-0,64%
Pepperstone
Advertisement
Registration Strip Icon for monitor Überwachen Sie mehrere Echtzeitkurse von führenden Börsen wie NASDAQ, NYSE, AMEX, Bovespa und mehr.
Registrieren
  1. Startseite
  2. Investieren
  3. Aktien
  4. USA
  5. USOTC
  6. Acura Pharmaceuticals Inc (CE) (ACUR)

  7. Acura Pharmaceuticals Inc (CE) (ACUR) News

ACUR

Acura Pharmaceuticals (CE) (ACUR)

Acura Pharmaceuticals Inc (CE)
Von:
Sortieren nach:
 Showing the most relevant articles for your search:USOTC:ACUR
DatumZeitQuelleÜberschriftSymbolFirma
04/02/202516h05Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesUSOTC:ACURAcura Pharmaceuticals Inc (CE)
24/01/202522h45Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesUSOTC:ACURAcura Pharmaceuticals Inc (CE)
24/01/202522h44Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesUSOTC:ACURAcura Pharmaceuticals Inc (CE)
24/01/202521h47Edgar (US Regulatory)Form 8-K - Current reportUSOTC:ACURAcura Pharmaceuticals Inc (CE)
21/11/202414h32Edgar (US Regulatory)Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSBUSOTC:ACURAcura Pharmaceuticals Inc (CE)
04/11/202421h00Edgar (US Regulatory)Form 8-K - Current reportUSOTC:ACURAcura Pharmaceuticals Inc (CE)
02/10/202417h16Edgar (US Regulatory)Form 8-K - Current reportUSOTC:ACURAcura Pharmaceuticals Inc (CE)
09/08/202420h44Edgar (US Regulatory)Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSBUSOTC:ACURAcura Pharmaceuticals Inc (CE)
26/07/202421h52Edgar (US Regulatory)Form 8-K - Current reportUSOTC:ACURAcura Pharmaceuticals Inc (CE)
04/06/202417h00Edgar (US Regulatory)Form 8-K - Current reportUSOTC:ACURAcura Pharmaceuticals Inc (CE)
15/05/202414h00Edgar (US Regulatory)Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSBUSOTC:ACURAcura Pharmaceuticals Inc (CE)
14/05/202422h40Edgar (US Regulatory)Form 8-K - Current reportUSOTC:ACURAcura Pharmaceuticals Inc (CE)
14/02/202416h53Edgar (US Regulatory)Form 8-K - Current reportUSOTC:ACURAcura Pharmaceuticals Inc (CE)
02/02/202416h27Edgar (US Regulatory)Form 8-K - Current reportUSOTC:ACURAcura Pharmaceuticals Inc (CE)
10/01/202423h13Edgar (US Regulatory)Form 8-K - Current reportUSOTC:ACURAcura Pharmaceuticals Inc (CE)
02/01/202421h23Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesUSOTC:ACURAcura Pharmaceuticals Inc (CE)
02/01/202421h23Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesUSOTC:ACURAcura Pharmaceuticals Inc (CE)
02/01/202421h20Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesUSOTC:ACURAcura Pharmaceuticals Inc (CE)
02/01/202421h20Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesUSOTC:ACURAcura Pharmaceuticals Inc (CE)
21/12/202318h01Edgar (US Regulatory)Form 8-K - Current reportUSOTC:ACURAcura Pharmaceuticals Inc (CE)
06/12/202320h35Edgar (US Regulatory)Form 8-K - Current reportUSOTC:ACURAcura Pharmaceuticals Inc (CE)
20/11/202318h08Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesUSOTC:ACURAcura Pharmaceuticals Inc (CE)
20/11/202318h08Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesUSOTC:ACURAcura Pharmaceuticals Inc (CE)
20/11/202318h07Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesUSOTC:ACURAcura Pharmaceuticals Inc (CE)
20/11/202318h07Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesUSOTC:ACURAcura Pharmaceuticals Inc (CE)
03/11/202317h42Edgar (US Regulatory)Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSBUSOTC:ACURAcura Pharmaceuticals Inc (CE)
12/10/202318h05Edgar (US Regulatory)Form 8-K - Current reportUSOTC:ACURAcura Pharmaceuticals Inc (CE)
25/09/202322h10Edgar (US Regulatory)Form 8-K - Current reportUSOTC:ACURAcura Pharmaceuticals Inc (CE)
01/09/202313h00Edgar (US Regulatory)Form 8-K - Current reportUSOTC:ACURAcura Pharmaceuticals Inc (CE)
31/08/202322h10Edgar (US Regulatory)Form 8-K - Current reportUSOTC:ACURAcura Pharmaceuticals Inc (CE)
 Showing the most relevant articles for your search:USOTC:ACUR

Kürzlich von Ihnen besucht

LSE
RR.
Rolls-royce
EU
FRI4G
Euronext France Investis...
CSE
QMET
Q Precious & Battery Met...
NASDAQ
CAPNX
Capital Group Emerging M...
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Deutschland
Unternehmen
Geschäft
Popular
App herunterladen
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

© 2025 ADVFN PLC - Alle Rechte vorbehalten

Werbung entfernen

Melden Sie sich für ein werbefreies Erlebnis an

Keine Werbung

Versuchen Sie es jetzt

Anzeigen behalten